Table 3.
Functional and clinical scores
| Functional and clinical tests | Results at different followup periods for each study group | |||||||
|---|---|---|---|---|---|---|---|---|
| Preoperatively | 3 months | 6 months | 12 months | |||||
| HR (N = 24) |
LDH THA (N = 24) |
HR (N = 24) |
LDH THA (N = 24) |
HR (N = 24) |
LDH THA (N = 24) |
HR (N = 24) |
LDH THA (N = 24) |
|
| WOMAC* | 46.5 (14.9) | 54.3 (14.5) | 15.2 (9.9) | 11.9 (16.1) | 7.0 (10.9) | 5.5 (15.0) | 3.0 (8.4) | 2.7 (8.5) |
| 26–79 | 30–80 | 3–39 | 0–36 | 1–42 | 0–29 | 0–12 | 0–16 | |
| SF-36: Mental* | 34.3 (8.1) | 35.1 (7.2) | 37.5 (11.5) | 41.2 (10.0) | 45.1 (14.5) | 54.3 (13.7) | 51.9 (7.2) | 52.1 (10.9) |
| 17–52 | 18–45 | 27–50 | 30–58 | 21–57 | 48–62 | 45–60 | 36–65 | |
| Physical* | 47.7 (10.1) | 46.8 (12.1) | 54.3 (11.4) | 53.4 (9.2) | 54.3 (5.2) | 57.6 (2.7) | 55.2 (5.1) | 53.3 (8.7) |
| 30–64 | 27–68 | 40–59 | 39–65 | 46–62 | 49–63 | 48–62 | 53–70 | |
| MA* | 11.0 (2.8) | 10.5 (2.3) | 17.0 (1.1) | 17.4 (1.0) | 17.5 (1.0) | 17.9 (1.1) | 17.9 (0.4) | 18.0 (0.0) |
| 7–16 | 5–16 | 14–18 | 16–18 | 14–18 | 16–18 | 16–18 | 18 | |
| UCLA activity* | — | — | — | — | — | — | 8.0 (1.5) | 8.3 (1.7) |
| 5–10 | 6–10 | |||||||
* The values are given as the mean (standard deviation), range; HR = hip resurfacing; LDH THA = large-diameter head THA; MA = Merle D’Aubigné; UCLA = University of California, Los Angeles.